Information for Persons Who Are Immunocompromised Regarding Prevention and Treatment of SARS-CoV-2 Infection in the Context of Currently Circulating Omicron Sublineages — United States, January 2023

This report describes measures that people who are immunocompromised can take to prevent and treat COVID-19.

Emergence of SARS-CoV-2 Omicron (B.1.1.529) variant, salient

Home page for MMWR

Mechanisms of Disease, COVID-19

400523 PDFs Review articles in MONOCLONAL ANTIBODIES

Roadmap

FDA Pulls Evusheld Authorization for Preventing COVID

Short-course early outpatient remdesivir prevents severe disease

Immune Network

JKMS :: Journal of Korean Medical Science